nystatin-a1 has been researched along with Immunologic-Deficiency-Syndromes* in 10 studies
3 review(s) available for nystatin-a1 and Immunologic-Deficiency-Syndromes
Article | Year |
---|---|
[General principles of antibiotic therapy and their use in the treatment of patients with immunologic deficiency syndromes].
Topics: Amphotericin B; Anti-Bacterial Agents; Antibody Formation; Bacitracin; Cephalosporins; Child; Humans; Immunity, Cellular; Immunoglobulins; Immunologic Deficiency Syndromes; Nystatin; Penicillins; Polymyxins; Structure-Activity Relationship | 1974 |
[Generalized candida mycoses].
Topics: Amphotericin B; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Burns; Candida albicans; Candidiasis; Catheterization; Central Nervous System Diseases; Diabetes Complications; Diagnosis, Differential; Fluorescent Antibody Technique; Fluorouracil; Hemagglutination Inhibition Tests; Humans; Hydrogen-Ion Concentration; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Lung Diseases, Fungal; Nystatin; Pneumonia, Pneumocystis; Pyelonephritis; Respiratory Hypersensitivity; Sepsis; Serologic Tests | 1974 |
Candida and candidiasis. 2. Clinical manifestations and therapy of candidal disease.
Topics: Amphotericin B; Candida; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Cheilitis; Female; Folliculitis; Gastrointestinal Diseases; Humans; Immunologic Deficiency Syndromes; Intertrigo; Leukoplakia, Oral; Male; Nystatin; Paronychia | 1973 |
7 other study(ies) available for nystatin-a1 and Immunologic-Deficiency-Syndromes
Article | Year |
---|---|
Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function.
In a patient with chronic esophageal candidiasis due to C. tropicalis that was refractory to mycostatin and ketoconazole, a generalized cell-mediated immunodeficiency state was detected. Samples of plasma from this patient inhibited T-lymphocyte function, suppressing both rosette formation and mitogen responsiveness of T-cells derived from the patient and from normal individuals. Following plasma exchange, the patient's immune defect resolved and her candida infection disappeared. On further analysis, the plasma inhibitory factor was found to be of low molecular weight (less than 10,000) and heat labile. Preliminary studies suggested that this inhibitor was candida-derived, since it was removed from plasma by anti-candida antibodies in solid phase. Immunodeficiency in chronic candidiasis may be improved by removal of circulating inhibitory factors through plasma exchange. Topics: Adult; Candidiasis; Esophageal Diseases; Female; Humans; Immunologic Deficiency Syndromes; Interleukin-2; Ketoconazole; Lymphokines; Molecular Weight; Nystatin; Rosette Formation; T-Lymphocytes | 1986 |
Candida infections.
The authors present a review of the epidemiology, pathology, diagnosis and treatment of candidiasis in the child. Their studies on the favoring factors in cutaneous forms as well as their experiences in pulmonary forms are emphasized. Topics: Amphotericin B; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Clotrimazole; Complement C5; Female; Flucytosine; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Miconazole; Nystatin | 1979 |
A case of chronic oropharyngo-esophageal candidiasis with immunological deficiency: successful treatment with miconazole.
The case of a 38-year-old male patient with chronic recurrent oropharyngo-esophageal candidiasis since early childhood, resistant to topical therapy with nystatin, is reported. The disease had resulted in impressive oropharyngeal lesions and stricturing of the midesophagus. Extensive in vivo and in vitro immunological studies done before and after successful treatment with miconazole showed a persistent partial deficiency of the cell-mediated immune system, in particular that directed toward candida antigens. Miconazole, a new potent antifungal drug, proved effective in controlling the candidiasis, which had become resistant to conventional treatment. Topics: Adult; Candidiasis; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Humans; Imidazoles; Immunity, Cellular; Immunologic Deficiency Syndromes; Male; Miconazole; Nystatin; Pharyngeal Diseases | 1977 |
[Therapy of generalized juvenile mycoses].
Topics: Amphotericin B; Antifungal Agents; Child; Clotrimazole; Drug Resistance; Flucytosine; Griseofulvin; Humans; Immunologic Deficiency Syndromes; Miconazole; Mycoses; Nystatin | 1976 |
[Diffuse chronic mucocutaneous candidiasis: Effects of antimycotics in vitro].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Cutaneous; Candidiasis, Oral; Child; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Flucytosine; Fluorouracil; Humans; Hypersensitivity, Delayed; Immunologic Deficiency Syndromes; Immunotherapy; Lymphocyte Activation; Microbial Sensitivity Tests; Nystatin; Skin Diseases; Staphylococcal Infections | 1975 |
Oral infections with Candida albicans.
Topics: Amphotericin B; Biopsy; Candida albicans; Candidiasis, Oral; Cheilitis; Diabetes Complications; Endocrine System Diseases; Fluorescent Antibody Technique; Humans; Immunity, Cellular; Immunologic Deficiency Syndromes; Leukoplakia, Oral; Metabolic Diseases; Nutrition Disorders; Nystatin; Sjogren's Syndrome; Stomatitis, Denture | 1973 |
Pulmonary candidosis.
Topics: Aerosols; Antibodies; Candidiasis; Child, Preschool; Humans; Immunologic Deficiency Syndromes; Lung Diseases, Fungal; Male; Nystatin | 1969 |